| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology
|
Kovacs, Gabor G.
|
|
2012
|
124 |
1 |
p. 37-50
|
article
|
| 2 |
Brain pathology of spinocerebellar ataxias
|
Seidel, Kay
|
|
2012
|
124 |
1 |
p. 1-21
|
article
|
| 3 |
CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma
|
Smith, Stuart J.
|
|
2012
|
124 |
1 |
p. 99-110
|
article
|
| 4 |
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
|
Toledo, Jon B.
|
|
2012
|
124 |
1 |
p. 23-35
|
article
|
| 5 |
Decreased pyramidal neuron size in Brodmann areas 44 and 45 in patients with autism
|
Jacot-Descombes, Sarah
|
|
2012
|
124 |
1 |
p. 67-79
|
article
|
| 6 |
Erratum to: Decreased pyramidal neuron size in Brodmann areas 44 and 45 in patients with autism
|
Jacot-Descombes, Sarah
|
|
2012
|
124 |
1 |
p. 81
|
article
|
| 7 |
Matrix metalloproteinase-12 deficiency ameliorates the clinical course and demyelination in Theiler’s murine encephalomyelitis
|
Hansmann, Florian
|
|
2012
|
124 |
1 |
p. 127-142
|
article
|
| 8 |
Mycoplasmal panencephalitis: a neuropathologic documentation
|
Powers, James M.
|
|
2012
|
124 |
1 |
p. 143-148
|
article
|
| 9 |
Persistent retroviral infection with MoMuLV influences neuropathological signature and phenotype of prion disease
|
Krasemann, Susanne
|
|
2012
|
124 |
1 |
p. 111-126
|
article
|
| 10 |
Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
|
Stefanova, Nadia
|
|
2012
|
124 |
1 |
p. 51-65
|
article
|
| 11 |
The “go or grow” potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress
|
Höring, Elisabeth
|
|
2012
|
124 |
1 |
p. 83-97
|
article
|
| 12 |
Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease
|
Mori, Fumiaki
|
|
2012
|
124 |
1 |
p. 149-151
|
article
|
Journal description